Testing effectiveness (Phase 2)Study completedNCT00764634
What this trial is testing
Double Blind, Safety and Immunogenicity Study of Recombinant Botulinum Vaccine A/B
Who this might be right for
Botulism Vaccine
DynPort Vaccine Company LLC, A GDIT Company 440